Fewer studies have focused on developing vaccine candidates with dual antigens from a single stage of malaria, such as CSP-TRAP47, Pfs48/45-230D133, and Pb22-Pbg3748, and from different stages of malaria such as ProC6C33, CSP/Pfs230D1/CoPoP49, CSP-Pfs2550 and GMZ2.6c51. Here, DNAJC5 is linked to malaria.